Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells

Details for Australian Patent Application No. 2005244625 (hide)

Owner Proyecto De Biomedicina Cima, S.L.

Inventors Smerdou Picazo, Cristian; Prieto Valtuena, Jesus; Qian, Cheng; Guan, Min

Agent Intellepro

Pub. Number AU-A-2005244625

PCT Pub. Number WO2005/112541

Priority P200401219 20.05.04 ES

Filing date 18 May 2005

Wipo publication date 1 December 2005

International Classifications

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2005/112541 Priority application(s): WO2005/112541

23 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244626-Cartilage and bone repair composition

2005244615-Vaccines